The protein encoded by the p53 tumour suppressor gene plays an important part in the regulation of cell growth. Abnormalities of this gene represent one of the most common genetic changes in the development of human cancers. This study investigated the expression of p53 protein in cholangiocarcinoma arising in association with primary sclerosing cholangitis (PSC) [265][266][267][268] 
P M Rizzi, S D Ryder, B Portmann, J K Ramage, N V Naoumov, Roger Williams Abstract The protein encoded by the p53 tumour suppressor gene plays an important part in the regulation of cell growth. Abnormalities of this gene represent one of the most common genetic changes in the development of human cancers. This study investigated the expression of p53 protein in cholangiocarcinoma arising in association with primary sclerosing cholangitis (PSC) . Of the 14 patients with cholangiocarcinoma studied, 13 had underlying PSC. The expression of p53 protein was detected immunohistochemically in paraffin wax embedded liver specimens, after microwave pretreatment. The expression of p53 protein was shown in the cholangiocarcinoma tissue of 11 of 14 (78/5%) patients. In five of 10 patients, the accumulation of p53 protein highlighted the presence of neoplastic cells in biliary tissue separate from the main tumour. These cells were mainly located in the septal bile ducts or in the accessory glands, or both, but occasionally also in large portal areas at the periphery of nerves In five of 10 patients with PSC and cholangiocarcinoma, screening of large tissue blocks including perihilar tissue showed, away from the main tumour area, small islands of biliary epithelium whose nuclei stained strongly for p53 protein (Fig 2) . These glandular elements were not noticed on the haematoxylin preparation because of their high degree of differentiation, which mimicked bile duct branches or islands of accessory seromucinous glands. In retrospect they appeared more consistent with highly differentiated tumour glands within thin walled lymphatic channels or distant foci of well differentiated., tubular adenocarcinoma, or both. In addition, minute nests of carcinoma cells were similarly highlighted within perineural tissue and lymphatics by nuclear p53 staining (Fig 3) . p53 protein staining, which allowed the recognition of minute tumour deposits.
The detection of mutant p53 protein has important implications for the clinical practice.15 16 It has recently been shown that p53 dependent apoptosis modulates the cytotoxic effects of ionising radiation and chemotherapy agents,'7 raising the possibility that the p53 gene participates in the mechanism of multidrug resistance.18 In patients with solid tumours both poor prognosis and failure of chemotherapy may be associated with the abnormalities of p53 mutations.15 The finding of a high prevalence of mutant p53 accumulation in cholangiocarcinoma may be linked with the rapid progression of this tumour and its poor response to different therapeutic approaches.
In a recent series of cholangiocarcinoma samples from Japan, overexpression of the p53 protein was detected in 22% of surgical tumour specimens. 19 In that study the underlying state of the liver is not described. 
